Combined with prognostic nutritional index and IgM for predicting the clinical outcomes of gastric cancer patients who received surgery
暂无分享,去创建一个
Haoran Sun | Yingwei Xue | H. Pan | Hongjiang Song | Rong Huang | Yanjiao Zuo | Ruihu Zhao | Gui-long Deng | Zhong-min Du
[1] Haoran Sun,et al. Prognostic nutritional index for predicting the clinical outcomes of patients with gastric cancer who received immune checkpoint inhibitors , 2022, Frontiers in Nutrition.
[2] Shulan Sun,et al. Predictive value of NLR and PLR in response to preoperative chemotherapy and prognosis in locally advanced gastric cancer , 2022, Frontiers in Oncology.
[3] Shuiping Huang,et al. Value of the prognostic nutritional index (PNI) in patients with newly diagnosed, CD5‐positive diffuse large B‐cell lymphoma: A multicenter retrospective study of the Huaihai Lymphoma Working Group , 2022, Cancer.
[4] Yasuhiro Chikaishi,et al. Serum immunogloblins might be useful predictors of immune‐related adverse events after immune checkpoint inhibitor usage in lung cancer , 2022, Thoracic cancer.
[5] Yahui Liu,et al. Prognostic Significance of PNI in Patients With Pancreatic Head Cancer Undergoing Laparoscopic Pancreaticoduodenectomy , 2022, Frontiers in Surgery.
[6] K. Beckmann,et al. Antibodies as biomarkers for cancer risk: a systematic review , 2022, Clinical and experimental immunology.
[7] Haoran Sun,et al. Controlling Nutritional Status (CONUT) Predicts Survival in Gastric Cancer Patients With Immune Checkpoint Inhibitor (PD-1/PD-L1) Outcomes , 2022, Frontiers in Pharmacology.
[8] Wanqing Chen,et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants , 2022, Chinese medical journal.
[9] D. Carbone,et al. Serum Albumin: Early Prognostic Marker of Benefit for Immune Checkpoint Inhibitor Monotherapy But Not Chemoimmunotherapy. , 2022, Clinical lung cancer.
[10] H. Kanemoto,et al. Serum carnitine as a biomarker of sarcopenia and nutritional status in preoperative gastrointestinal cancer patients , 2021, Journal of cachexia, sarcopenia and muscle.
[11] A. Gavin,et al. International variation in oesophageal and gastric cancer survival 2012–2014: differences by histological subtype and stage at diagnosis (an ICBP SURVMARK-2 population-based study) , 2021, Gut.
[12] L. Xu,et al. 124例成人噬血细胞综合征临床预后分析:一项淮海淋巴瘤协作组多中心回顾性研究 , 2021, Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi.
[13] Kailin Xu,et al. Prognostic values of geriatric nutritional risk index (GNRI) and prognostic nutritional index (PNI) in elderly patients with Diffuse Large B-Cell Lymphoma , 2021, Journal of Cancer.
[14] Shuiping Huang,et al. The Value of Prognostic Nutritional Index (PNI) on Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients: A Multicenter Retrospective Study of HHLWG Based on Propensity Score Matched Analysis , 2021, Journal of inflammation research.
[15] C. Kou,et al. Prognostic role of the prognostic nutritional index (PNI) in patients with head and neck neoplasms undergoing radiotherapy: A meta-analysis , 2021, PloS one.
[16] F. Tan,et al. Association between pre‐diagnostic serum albumin and cancer risk: Results from a prospective population‐based study , 2021, Cancer medicine.
[17] X. Kong,et al. Prognostic Nutritional Index (PNI) in Patients With Breast Cancer Treated With Neoadjuvant Chemotherapy as a Useful Prognostic Indicator , 2021, Frontiers in Cell and Developmental Biology.
[18] P. Ravasco,et al. ESPEN practical guideline: Clinical Nutrition in cancer. , 2021, Clinical nutrition.
[19] Myung-Gyu Choi,et al. Association between absolute lymphocyte count and overall mortality in patients with surgically resected gastric cancer , 2021, The Korean journal of internal medicine.
[20] A. Jemal,et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries , 2021, CA: a cancer journal for clinicians.
[21] G. Kijanka,et al. IgM and IgA augmented autoantibody signatures improve early‐stage detection of colorectal cancer prior to nodal and distant spread , 2021, Clinical & translational immunology.
[22] T. S. S. Pereira,et al. Malnutrition and nutrition impact symptoms (NIS) in surgical patients with cancer , 2020, PloS one.
[23] A. Shen,et al. Combining the Fibrinogen-to-Pre-Albumin Ratio and Prognostic Nutritional Index (FPR-PNI) Predicts the Survival in Elderly Gastric Cancer Patients After Gastrectomy , 2020, OncoTargets and therapy.
[24] Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.
[25] Lan Xu,et al. Evaluation of IgG, IgM, CD4+ and CD8+ T cells during neoadjuvant chemotherapy with Tezio and Apatinib in gastric cancer patients. , 2020, Cellular and molecular biology.
[26] K. Shiu,et al. Challenges in the treatment of gastric cancer in the older patient. , 2020, Cancer treatment reviews.
[27] S. Natsugoe,et al. Combined neutrophil-lymphocyte ratio and platelet-lymphocyte ratio predicts chemotherapy response and prognosis in patients with advanced gastric cancer , 2019, BMC cancer.
[28] E. Kay,et al. Measurement of the IgM and IgG Autoantibody Immune Responses in Human Serum has High Predictive Value for the Presence of Colorectal Cancer , 2019, Clinical colorectal cancer.
[29] Vítor Devezas,et al. The impact of the prognostic nutritional index (PNI) in gastric cancer , 2019, Langenbeck's Archives of Surgery.
[30] N. Deutz,et al. Specialized High‐Protein Oral Nutrition Supplement Improves Home Nutrient Intake of Malnourished Older Adults Without Decreasing Usual Food Intake , 2018, JPEN. Journal of parenteral and enteral nutrition.
[31] R. Torres,et al. Immune Surveillance by Natural IgM Is Required for Early Neoantigen Recognition and Initiation of Adaptive Immunity , 2018, American journal of respiratory cell and molecular biology.
[32] Chang-ming Huang,et al. CRP/prealbumin, a novel inflammatory index for predicting recurrence after radical resection in gastric cancer patients: post hoc analysis of a randomized phase III trial , 2018, Gastric Cancer.
[33] D. Waitzberg,et al. Nutritional Therapy in Gastrointestinal Cancers. , 2017, Gastroenterology clinics of North America.
[34] W. Guan,et al. Postoperative decrease of serum albumin predicts short-term complications in patients undergoing gastric cancer resection , 2017, World journal of gastroenterology.
[35] R. Knols,et al. Effects of nutrition and physical exercise intervention in palliative cancer patients: A randomized controlled trial. , 2017, Clinical nutrition.
[36] M. Kontogianni,et al. Detailed Dietary Assessment in Patients with Inoperable Tumors: Potential Deficits for Nutrition Care Plans , 2016, Nutrition and cancer.
[37] T. Yoshikawa,et al. Survival results of a randomised two-by-two factorial phase II trial comparing neoadjuvant chemotherapy with two and four courses of S-1 plus cisplatin (SC) and paclitaxel plus cisplatin (PC) followed by D2 gastrectomy for resectable advanced gastric cancer. , 2016, European journal of cancer.
[38] T. Nagykálnai,et al. [Cachexia in cancer patients]. , 2016, Magyar onkologia.
[39] G. Freeman,et al. Combination cancer immunotherapy and new immunomodulatory targets , 2015, Nature Reviews Drug Discovery.
[40] P. Ostoa-Saloma,et al. Natural and adaptive IgM antibodies in the recognition of tumor-associated antigens of breast cancer (Review) , 2015, Oncology reports.
[41] S. Choi,et al. Absolute monocyte and lymphocyte count prognostic score for patients with gastric cancer. , 2015, World journal of gastroenterology.
[42] S. Clarke,et al. Cancer-related inflammation and treatment effectiveness. , 2014, The Lancet. Oncology.
[43] C. Leemans,et al. Effect of nutritional interventions on nutritional status, quality of life and mortality in patients with head and neck cancer receiving (chemo)radiotherapy: a systematic review. , 2013, Clinical nutrition.
[44] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[45] S. Kaveri,et al. Natural IgM in Immune Equilibrium and Harnessing Their Therapeutic Potential , 2012, The Journal of Immunology.
[46] Y. Bang,et al. Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial , 2012, The Lancet.
[47] Joon-Oh Park,et al. Phase III trial comparing capecitabine plus cisplatin versus capecitabine plus cisplatin with concurrent capecitabine radiotherapy in completely resected gastric cancer with D2 lymph node dissection: the ARTIST trial. , 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[48] K. Fearon. Cancer cachexia: developing multimodal therapy for a multidimensional problem. , 2008, European journal of cancer.
[49] F. Schmidt. Meta-Analysis , 2008 .
[50] M. Tattersall,et al. Prognostic factors in patients with recently diagnosed incurable cancer: a systematic review , 2006, Supportive Care in Cancer.
[51] A. Sanabria,et al. Randomized controlled trial. , 2005, World journal of surgery.
[52] H. Espejo,et al. [Gastric cancer]. , 1996, Revista de gastroenterologia del Peru : organo oficial de la Sociedad de Gastroenterologia del Peru.